Clinical characteristics of patients with lung cancer and idiopathic pulmonary fibrosis in China

Thoracic Cancer

Volumn 3, Issue 2, 2012, Pages 156-161

  Zhong, Yan Xu ^a   Zhang, Li ^a   Zhao, Jing ^a   Li, Longyun ^a   Wang, Mengzhao ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Ipf; Lung cancer; Lung cancer treatment; Tumor markers

Indexed keywords

CA 19-9 ANTIGEN; CA 242 ANTIGEN; CA 50 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; ENOLASE; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CHINA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DYSPNEA; FEMALE; FOLLOW UP; HEMOPTYSIS; HISTOLOGY; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC DISEASE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG FIBROSIS; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRIORITY JOURNAL; SMOKING; TACHYPNEA; THORAX PAIN; THORAX RADIOGRAPHY; WEIGHT REDUCTION;

EID: 84868158399     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/j.1759-7714.2012.00108.x     Document Type: Article

References (23)

1. Matsushita H, Tanaka S, Saiki Y et al. Lung cancer associated with usual interstitial pneumonia. Pathol Int 1995; 45: 925-32.
2. Wells C,Mannino DM. Pulmonary fibrosis and lung cancer in the United States: analysis of themultiple cause of death mortality data, 1979 through 1991. SouthMed J 1996; 89: 505-10.
3. Ma Y, Seneviratne CK, Koss M. Idiopathic pulmonary fibrosis and malignancy. Curr Opin PulmMed 2001; 7: 278-82.
4. Le Jeune I,Gribbin J,West J, Smith C, Cullinan P,Hubbard R. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. RespirMed 2007; 101: 2534-40.
5. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest 2009; 136: 260-71.
6. Samet JM. Does idiopathic pulmonary fibrosis increase lung cancer risk? Am J Respir Crit CareMed 2000; 161: 1-2.
7. Daniels CE, Jett JR. Does interstitial lung disease predispose to lung cancer? Curr Opin PulmMed 2005; 11: 431-7.
8. Yamanouchi H, Ohtsuki Y, Fujita J, Bandoh S, Yoshinouchi T, Ishida T. The distribution and number of Leu-7 (CD57) positive cells in lung tissue from patients with pulmonary fibrosis. ActaMed Okayama 2002; 56: 83-9.
9. Takahashi T,Munakata M, Ohtsuka Y et al. Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis. Cancer 2002; 95: 624-33.
10. Nagai A, Chiyotani A,Nakadate T, Konno K. Lung cancer in patients with idiopathic pulmonary fibrosis. Tohoku J Exp Med 1992; 167: 231-7.
11. Ricci A,Mariotta S, Bronzetti E et al. Serum CA 15-3 is increased in pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2009; 26: 54-63.
12. Fujita J,Obayashi Y,Yamadori I et al. Marked elevation of CA19-9 in a patientwith idiopathic pulmonary fibrosis: CA19-9 as a bad prognostic factor.Respirology 1998; 3: 211-14.
13. Shimizu Y,Hamada T, Tanaka Y, Sasaki A,Nemoto T. Colocalization of CA19-9 and KL-6 to epithelial cells in dilated bronchioles in a patient with idiopathic pulmonary fibrosis complicated by diffuse alveolar damage. Respirology 2002; 7: 281-4.
14. Takayama S, Kataoka N,Usui Y et al. CA 19-9 in patients with benign pulmonary diseases.Nihon Kyobu Shikkan Gakkai Zasshi 1990; 28: 1326-31.
15. Hadjiliadis D, Tapson VF, Davis RD, Palmer SM. Prognostic value of serum carcinoembryonic antigen levels in patients who undergo lung transplantation. J Heart Lung Transplant 2001; 20: 1305-9.
16. Nakayama M, Satoh H, Ishikawa H et al. Cytokeratin 19 fragment in patients with nonmalignant respiratory diseases. Chest 2003; 123: 2001-6.
17. Sakai S,Ono,M,Nishio T,Kawarada Y,Nagashima A, Toyoshima S. Lung cancer associatedwith diffuse pulmonary fibrosis:CT-pathologic correlation. J Thorac Imaging 2003; 18: 67-71.
18. Gould MK, Fletcher J, IannettoniMD et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132 (Suppl.): 108S-30S.
19. Lee HJ, ImJG, Ahn JM, Yeon KM. Lung cancer in patients with idiopathic pulmonary fibrosis: CT findings. J Comput Assist Tomogr 1996; 20: 979-82.
20. Mizushima Y, Kobayashi M. Clinical characteristics of synchronousmultiple lung cancer associated with idiopathic pulmonary fibrosis.A review of Japanese cases. Chest 1995; 108: 1272-7.
21. Watanabe A,Higami T, Ohori S, Koyanagi T,Nakashima S, Mawatari T. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg 2008; 136: 1357-63.
22. Kong FM, Ten Haken R, Eisbruch A, Lawrence TS. Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis. Semin Oncol 2005; 32 (Suppl.): S42-54.
23. Liu V, White DA, Zakowski MF, et al. Pulmonary toxicity associated with erlotinib. Chest 2007; 132: 1042-4.